NCT02182674View on ClinicalTrials.gov

A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

August 31, 2001

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Placebo Combivent HFA

DRUG

Combivent HFA

DRUG

Combivent (CFC)

DRUG

Placebo Combivent (CFC)

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY